In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on GH Research (GHRS – Research Report), with a price ...

JMP Securities reiterated its Market Outperform rating on AN2 Therapeutics (NASDAQ:ANTX) shares, maintaining a $5.00 price target, representing significant upside from the current price of $1.14.

In a report released today, Matthew Condon from JMP Securities reiterated a Buy rating on Roku (ROKU – Research Report), with a price target of ...

JMP Securities reaffirmed its Market Outperform rating on Roku Inc. (NASDAQ:ROKU) with a steady price target of $95.00. According to InvestingPro data, Roku's stock has shown significant momentum with ...

Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...

Narwhal Capital Management acquired a new stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) in the fourth quarter, ...

Latest Analyst Ratings And Upgrades. In this article, we are going to take a look at where DigitalOcean Holdings Inc.

JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and ...

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...

Healthcare Analysts provide an update to the Urticaria Landscape (relevant companies CLDX JSPR ALLK) on an Analyst/Industry conference call to be held on January 10. TipRanks is the most ...

Truist also published new coverage on Cloudflare today, maintaining a buy rating on the stock and raising its one-year price target from $120 per share to $140 per share. Notably, today's gains pushed ...

We recently compiled a list of the 10 Trending AI Stocks on Wall Street’s Radar. In this article, we are going to take a look ...